Superworth

Zimmer Biomet price to book ratio ZBH

Market value divided by the book value of the company's net assets, since 2009.

Today, Oct 23, 2026
1.5×
10-year median
2.0×
Against its 10-year history
10th
percentile: 0 is its lowest day, 100 its highest
10-year range
1.3× to 2.9×
Peer median
3.4×

Zimmer Biomet's price to book ratio is 1.5× as of Oct 23, 2026.

That is below its ten-year median of 2.0×, lower than on 90% of days in the last ten years.

Over that time it ranged from 1.3× in May 2026 to 2.9× in Apr 2021.

The median for 10 medical device stocks of a similar size is 3.4×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.5×1.3×1.5×
20251.4×1.4×1.8×
20241.7×1.6×2.2×
20232.0×1.7×2.5×
20222.2×1.8×2.2×
20212.0×1.9×2.9×
20202.6×1.4×2.6×
20192.5×1.7×2.5×
20181.7×1.6×2.4×
20172.3×2.1×2.6×
20162.1×1.8×2.7×
20152.0×1.8×3.1×
20142.9×2.4×2.9×
20132.5×2.0×2.5×
20121.9×1.7×2.0×
20111.7×1.5×2.2×
20101.8×1.6×2.1×
20092.0×1.7×2.1×

Against its peers

Companies in Medical - Devices nearest Zimmer Biomet's size, closest first, today.

CompanyPrice to book ratio
ZBHZimmer Biomet1.5×
DXCMDexCom11.2×
GEHCGE HealthCare Technologies2.9×
EWEdwards Lifesciences4.8×
BSXBoston Scientific2.7×
LIVNLivaNova3.4×
ITGRInteger2.5×
SYKStryker4.9×
MDTMedtronic2.4×
TMDXTransMedics4.7×
ABTAbbott Laboratories3.5×
Peer median3.4×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Zimmer Biomet

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.